Leerink analyst Jonathan Chang raised the firm’s price target on Replimune (REPL) to $21 from $18 to reflect an increased probability of ...

Stephens Inc. AR reduced its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 4.3% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 14,439 shares ...

Danielle said she hopes to 'raise awareness' of the symptoms to look out for after receiving her own diagnosis - here's the ...

H.C. Wainwright analyst Raghuram Selvaraju increased the price target on Replimune Group (NASDAQ:REPL), currently trading at $13.79 with a market cap of $1.06 billion, to $22.00, up from the previous ...

Danielle Lloyd has revealed she has been diagnosed with a form of skin cancer and has urged people to see a doctor if they have noticed changes to their skin. As a mother of five, 41-year-old Lloyd ...

A benefit for South Lake Tahoe local Jennifer Milligin, who is recovering from Ocular Melanoma (eye cancer), will be held at ...

Danielle Lloyd has revealed she has been diagnosed with a form of skin cancer and has urged people to see a doctor if they ...

Nations Financial Group Inc. IA ADV lowered its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 10.3% in ...

Dec. 17, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to - IMM-1-104 has the potential to benefit melanoma patients who have ...

Helen Torley; President, Chief Executive Officer, Director; Halozyme Therapeutics Inc Nicole Labrosse; Chief Financial Officer, Senior Vice President; Halozyme Therapeutics Inc Good afternoon. My name ...

Question: I recently noticed a strange growth on my bottom eyelid. It isn’t coming out of a hair follicle, and it isn’t a ...

Imugene's trial programs could result in the first 'off the shelf' Car-T therapy that uses healthy donors' cells.